Title : CD45RB is a novel molecular therapeutic target to inhibit Abeta peptide-induced microglial MAPK activation.

Pub. Date : 2008 May 14

PMID : 18478117






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 To investigate the mechanism(s) involved, microglial cells were co-treated with a PTP inhibitor (potassium bisperoxo [1,10-phenanthroline oxovanadate; Phen]) and Abeta(1-42) peptides. 1,10-phenanthroline protein tyrosine phosphatase receptor type U Homo sapiens